N-Deshydroxyethyl Dasatinib is a metabolite of the anticancer drug Dasatinib and a key component in the SNIPER molecule BMS-354825, which targets ABL for degradation. This research compound is utilized in biochemical studies to investigate targeted protein degradation strategies in cancer and immunological research, both in vitro and in vivo.